Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for chemotherapy-induced thrombocytopenia in AML
NCT02244658Phase 3Unknown
- Sponsor
- Shandong University
- Start
- Sep 2014
- Primary completion
- Jun 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by Shandong University. Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02244658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244658.